Sovereign Pharma, a leader in high-quality injectable manufacturing, proudly announces its milestone: EU approval for aseptic ...

Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:45 Hrs [IST] Sovereign Pharma, ...

Rameda’s standalone net profits after tax slipped to EGP 373.237 million in 2024, compared to EGP 234.455 million in 2023 ...

Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced ...

Telangana: Gland Pharma has appointed Wriddhee Maitra as Vice-President (Human Resources), a Senior Management Personnel of ...

Curia will expand its Glasgow, UK facility and offers updates on the ongoing expansion to its Albuquerque, NM facility.

Already known for its antibody drug conjugates (ADCs), lipid nanoparticles (LNPs), lyophilization development ... increasing batch sizes up to 20,000 vials, the new capacity will feature robotic ...

Alina's presentation is forming a part on the programme devoted to the topic of 'Beyond vial Lyophilization' with the outlook at alternatives to conventional methods. Another presentation of this ...